- Report
- April 2021
China
From €2499EUR$2,600USD£2,143GBP
- Report
- May 2021
- 43 Pages
Global
€1267EUR$1,318USD£1,086GBP
- Report
- April 2021
- 73 Pages
Global
€21145EUR$22,000USD£18,133GBP
- Drug Pipelines
- September 2019
- 118 Pages
Global
€9612EUR$10,000USD£8,242GBP
- Drug Pipelines
- September 2019
- 30 Pages
Global
€9612EUR$10,000USD£8,242GBP
- Report
- September 2019
- 29 Pages
Global
€9612EUR$10,000USD£8,242GBP
- Report
- September 2019
- 28 Pages
Global
€9612EUR$10,000USD£8,242GBP
- Report
- February 2019
- 222 Pages
Global
From €21145EUR$22,000USD£18,133GBP
- Report
- February 2021
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- March 2023
- 157 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- March 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- March 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- December 2021
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- September 2022
- 30 Pages
Global
From €1874EUR$1,950USD£1,607GBP
- Report
- August 2022
Global
From €1144EUR$1,190USD£981GBP
- Report
- August 2022
United States
From €1865EUR$1,940USD£1,599GBP
- Report
- August 2021
Europe
From €3287EUR$3,420USD£2,819GBP
- Report
- August 2021
Global
From €3835EUR$3,990USD£3,289GBP
- Report
- February 2021
Global
From €2845EUR$2,960USD£2,440GBP
- Report
- March 2021
- 214 Pages
Global
From €10568EUR$10,995USD£9,062GBP
The Liver Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat liver cancer. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells. Immunotherapy is a type of drug that works by stimulating the body's own immune system to fight cancer.
The Liver Cancer Drugs market is highly competitive, with many companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly developing new drugs and treatments to improve the quality of life for those affected by liver cancer. Show Less Read more